Literature DB >> 31166078

Novel BQCA- and TBPB-Derived M1 Receptor Hybrid Ligands: Orthosteric Carbachol Differentially Regulates Partial Agonism.

Simon Schramm1, Luca Agnetta1, Marcel Bermudez2, Hubert Gerwe1, Matthias Irmen3, Janine Holze3, Timo Littmann4, Gerhard Wolber2, Christian Tränkle3, Michael Decker1.   

Abstract

Recently, investigations of the complex mechanisms of allostery have led to a deeper understanding of G protein-coupled receptor (GPCR) activation and signaling processes. In this context, muscarinic acetylcholine receptors (mAChRs) are highly relevant due to their exemplary role in the study of allosteric modulation. In this work, we compare and discuss two sets of putatively dualsteric ligands, which were designed to connect carbachol to different types of allosteric ligands. We chose derivatives of TBPB [1-(1'-(2-tolyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one] as M1 -selective putative bitopic ligands, and derivatives of benzyl quinolone carboxylic acid (BQCA) as an M1 positive allosteric modulator, varying the distance between the allosteric and orthosteric building blocks. Luciferase protein complementation assays demonstrated that linker length must be carefully chosen to yield either agonist or antagonist behavior. These findings may help to design biased signaling and/or different extents of efficacy.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  GPCRs; allostery; dualsteric ligands; muscarinic receptors; partial agonists

Mesh:

Substances:

Year:  2019        PMID: 31166078     DOI: 10.1002/cmdc.201900283

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  3 in total

1.  Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders.

Authors:  Meng Cheng; Xufen Yu; Kaylene Lu; Ling Xie; Li Wang; Fanye Meng; Xiaoran Han; Xian Chen; Jing Liu; Yue Xiong; Jian Jin
Journal:  J Med Chem       Date:  2020-01-14       Impact factor: 7.446

2.  Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease.

Authors:  Pavan Kumar Chintamaneni; Praveen Thaggikuppe Krishnamurthy; Sai Kiran S S Pindiprolu
Journal:  RSC Adv       Date:  2021-01-28       Impact factor: 3.361

Review 3.  The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.

Authors:  Attila Egyed; Dóra Judit Kiss; György M Keserű
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.